Key statistics
On Friday, Vistagen Therapeutics Inc (VTGN:NAQ) closed at 3.15, 28.57% above the 52 week low of 2.45 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.03 |
---|---|
High | 3.20 |
Low | 2.98 |
Bid | 2.97 |
Offer | 3.25 |
Previous close | 3.00 |
Average volume | 150.83k |
---|---|
Shares outstanding | 27.06m |
Free float | 26.99m |
P/E (TTM) | -- |
Market cap | 85.22m USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update
- Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024
- Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine
- Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year